Wednesday 4th december

Thursday 5th december

Room A

Room A

Jenifer Lightdale

Rodrigo Vázquez Frías

Marcelo R Risk

Room A

Carlo Catassi

Nelson Ramirez-Rodriguez

627/193. POTENTIAL COELIAC DISEASE IN A PROSPECTIVE COHORT OF SPANISH COELIAC CHILDREN: CHARACTERISTICS AT DIAGNOSIS AND SHORT-TERM FOLLOW-UP

627/165. DIAGNOSTIC DELAYS IN CHILDREN WITH CELIAC DISEASE ACROSS THE WORLD

627/511. NON-BIOPSY APPROACH FOR NORTH AMERICAN PEDIATRIC PATIENTS WITH CELIAC DISEASE

627/193 Potential coeliac disease in a prospective cohort of spanish coeliac children: characteristics at diagnosis and short-term follow-up

Josefa Barrio

Something new in celiac disease follow-up?

Jernej Dolinsek

627/165 Diagnostic delays in children with celiac disease across the world

Jernej Dolinsek

627/511 Non-biopsy approach for north american pediatric patients with celiac disease

Ugur Halac

Are we overdiagnosing gluten related disorders?

Alessio Fasano

In GRD, are we talking about a transitory pathology or a lasting disorder?

Aw Marion

Room B

Paul Harris

Harland Winter

627/535. Global Burden and Health Inequality of Nutritional Deficiencies from 1990-2019

627/687. MATERNAL AND OFFSPRING NEURODEVELOPMENTAL OUTCOMES FOLLOWING GESTATIONAL ANTIBIOTIC TREATMENT AND PERINATAL ASPHYXIA: PROBIOTIC POTENTIAL

627/194. An ecological study of the association between childhood stunting, water, sanitation, and protein access, 2001-20

Climate, Enviromental contamination and global child health equity.

Mark Manary

627/535 Global Burden and Health Inequality of Nutritional Deficiencies from 1990-2019

Hui Li

Innovations in Pediatric Global Health: the role of machine learning and AI in global child health

Sana Syed

627/687 Maternal and offspring neurodevelopmental outcomes following gestational antibiotic treatment and perinatal asphyxia: probiotic potential

Mara Ioana Ionescu

Global challenges in childhood nutrition; from undernutrition to obesity

Mary Fewtrell

627/194 An ecological study of the association between childhood stunting, water, sanitation, and protein access, 2001-20

Thomas Wallach

Room C1

Giuseppe Indolfi

Sandeep Gupta

The Editorial Team with moderated questions and answers

Joseph Croffie

Norman Junge

Osvaldo Borrelli

Anupama Chawla

How to transform abstracts into publishable JPGN/JPGN Reports articles

Kathleen Schwarz

Nitika Gupta

Room C2

Ulrich Baumann

Marcela Godoy

627/227. BILIARY ATRESIA IN THE EAST AND THE WEST: HEAD-TO-HEAD COMPARISON OF CLINICAL OUTCOMES IN TWO TERTIARY HOSPITALS

627/613. Liver copper in children with Wilson disease – sensivity, specifity and optimal cut-off concentration.

627/75. FIND OUT THE SITUATION ABOUT THE DIAGNOSIS AND FOLLOW-UP OF PATIENTS WITH TYROSINEMIA TYPE-1 IN LATIN AMERICA

Management of small babies with liver disease: how to grow them pre-transplant

Vicky Lee Ng

627/227 Biliary atresia in the east and the west: head-to-head comparison of clinical outcomes in two tertiary hospitals

Mark Nomden

Autoimmune hepatitis interplay with sclerosing cholangitis in IBD. Evaluation and prognosis

Lorenzo D'Antiga

627/613 Liver copper in children with Wilson disease – sensivity, specifity and optimal cut-off concentration

Piotr Socha

627/75 Find out the situation about the diagnosis and follow-up of patients with tyrosinemia type-1 in Latin America

Veronica Cornejo

Portal hypertension in children: challenges and persistent dilemmas

Riccardo Superina

Room C3

Magali Reyes Apodaca

Carmen Alicia Sanchez Ramirez

627/428. Anthropometric and lung function modifications in patients with cystic fibrosis from a pediatric hospital in Buenos Aires treated with highly effective CRFT Modulators.

627/147. "Survey insights: Challenges and successes of cystic fibrosis care in Latin America".

627/28. UTILIZING THE TRINETX INTERNATIONAL DATABASE OF RARE DISEASE: GI MANIGESTATIONS IN CHILDREN AND YOUNG ADULTS WITH CYSTIC FIBROSIS IN THE PRE AND POST HIGHLY EFFECTIVE TRIPLE MODULATOR THERAPY ERA

627/147 Survey insights: Challenges and successes of cystic fibrosis care in Latin America

Magali Reyes Apodaca

The Impact of CFTR Modulators on gastrointestinal symptomatology

Meghana Sathe

627/428 Anthropometric and lung function modifications in patients with cystic fibrosis from a pediatric hospital in Buenos Aires treated with highly effective CRFT Modulators

Florencia Bocco

627/28 Utilizing the TRINETX international database of rare disease: GI manifestations in children and young adults with cystic fibrosis in the pre and post highly effective triple modulator

Carolena Trocchia

Redefining liver disease in CF: new guidelines and definitions

Simon Ling

The pancreas and liver in cystic fibrosis-related disorders

Michael Wilschanski

Room D

Sanja Kolaček

Catalina Bages

627/91. EFFECT OF COVID PANDEMIC ON GROWTH STATUS AMONG YOUNG MALAYSIAN CHILDREN: A COMPARATIVE ANALYSIS FROM THREE NATIONWIDE SURVEYS

627/409. A STATISTICAL EXPLORATION OF PEDIATRIC GASTROSTOMY COMPLICATIONS: INSIGHTS FROM A TERTIARY CARE CENTER IN SRI LANKA

627/606. GASTRIC RESIDUAL MEASUREMENT IN PRETERM INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Practical interventions for managing malnutrition in children under 5 years of age in low- and middle-income countries

Solange Heller Rouassant

627/91 Effect of COVID pandemic on growth status among young Malaysian children: a comparative analysis from three nationwide surveys

Lee Way Seah

627/409 A statistical exploration of pediatric gastrostomy complications: insights from a tertiary care center in Sri Lanka

Kapuge Lasanthi Wathsala Hathagoda

Micronutrient supplementation and fortification in children under 5 years

Krishnapriya M Prathapan

627/606 Gastric residual measurement in preterm infants: a systematic review and meta-analysis of randomized controlled trials

Angelica Nau

Feeding the premature infant: Individualized feeding plans and complementary feeding

Ariel Salas

Room E

Lissy de Ridder

Dianora Coromoto Navarro Aponte

627/465. 5 YEARS TERTIARY EXPERIENCE IN BUTTON BATTERY INGESTIONS - CHILDREN CONTINUE TO DIE FROM BUTTON BATTERIES

627/822. Outcome and parent’s satisfaction from modified open access endoscopy versus traditional endoscopy referral in children

627/81. IMPROVEMENT OF ENDOSCOPIC SKILLS AFTER COMPLETION OF A SIMULATION COURSE FOR PEDIATRIC RESIDENTS

627/465 Five years tertiary experience in button battery ingestions - children continue to die from button batteries

Christos Tzivinikos

Current situation of endoscopy training in the Asian-Pacific region

Katsuhiro Arai

Simulators and other trends in endoscopy training

Jenifer Lightdale

627/822 Improvement of endoscopic skills after completion of a simulation course for pediatric residents

Ron Shaoul

New colonoscopy quality indicators

Reinaldo Pierre-Alvarez

627/81 Outcome and parent’s satisfaction from modified open access endoscopy versus traditional endoscopy referral in children

Alicia Cañizares Funes

Room A

Oscar Javier Quintero Hernández

Rosan Meyer

Christophe Dupont

Room C1

Yvan Vandenplas

Rodrigo Vázquez Frías

Mario Vieira

Room C2

Progressive Familial Intrahepatic cholestasis (PFIC): where are we?

Elisa De Carvalho

A new standard of care for patients with PFIC

Ulrich Baumann

Improving outcomes in the real world across PFIC types & ALGS

Richard Thompson

Room C3

Daniel D'Agostino

12.30 - 12.45 h. ALGS and PFIC: Experience in Diagnosis and Treatment at the Hospital Italiano of Buenos Aires

Gustavo Boldrini

12.45 - 13.00 h. Barriers in the Diagnosis and Treatment of ALGS and PFIC: Colombian Perpective and Experience

Felipe Ordoñez Guerrero

13.00 - 13.15 h. Advancements and Strengths in the Diagnosis of ALGS ans PFIC in Brazil: Success Stories

Gilda Porta

13.15 - 13.30 h. New Molecules for the Treatment of ALGS and PFIC: Experiences with IBATs at Valld´Hebron Hospital

Jesús Quintero Bernabeu

Room D

Alessio Fasano

Room E

Barriers and Challenges in Cross-Cultural Dietary Adaptation: Insights on Regional Clinical Practice

Soledad Arcucci

New Scenarios in Dietary Management and Combined Therapy with Advance Drugs

Francisco Javier Martín de Carpi

Expanding Indications for Nutritional Therapy in Pediatric Crohn Disease: beyond Induction of Remission in Mild-Moderate Disease

Eytan Wine

Room A

Stefano Guandalini

Gabriel Vinderola

Restoring premature microbiome maturation through probiotics and nutrition strategies

Marie Claire Arrieta

The fiability of HMO in different situations

Yvan Vandenplas

The use of gum arabic as natural prebiotic in the management of acute diarrhea

Omayma Sabir

Evidence-based indications for probiotics

Hania Szajewska

Room B

Cristina Targa Ferreira

Mauro Batista de Morais

627/358. DUPILUMAB IN PEDIATRIC REFRACTORY EOSINOPHILIC ESOPHAGITIS: A RETROSPECTIVE STUDY ON CLINICAL ,ENDOSCOPIC AND HISTOLOGICAL RESPONSE - TRIPLE REMISSION IS AN ACHIEVABLE GOAL

627/601. ARTIFICIAL INTELLIGENCE USE TO PREDICT PROTON PUMP INHIBITOR RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A DIAGNOSTIC ACCURACY STUDY

Induction of cow milk protein tolerance in cow milk allergy: where are we?

Roberto Berni Canani

Impact of food allergy on quality of life and financial burden: a worldwide perspective

Dominique Bailey

627/145 Gut microbiome of Brazilian infants with non-IgE mediated cow’s milk allergy – a pilot study

Bruna França Protásio

627/358 Dupilumab in pediatric refractory eosinophilic esophagitis: a retrospective study on clinical, endoscopic and histological response - triple remission is an achievable goal

Christos Tzivinikos

The role of STAT-6 in eosinophilic gastrointestinal disorder and other allergic diseases

Ichro Takeuchi

627/601 Artificial intelligence use to predict proton pump inhibitor response in patients with eosinophilic esophagitis: a diagnostic accuracy study

Rian Lima

Room C1

Anupam Sibal

Sanja Kolaček

NASPGHAN Experience with Entrustable Professional Activities (EPA)

Cary Sauer

Developing research in resource-limited areas: a tool for global equity

Robert Bandsma

Insights into successful mentor-mentee relationship

Taoufik Meskini

Building global networks: Latinamerica´s vision for worldwide gastroenterology education

María Alejandra Mortarini

Training systems across different countries and inequities

Anne Marie Grima

Room C2

Giuseppe Indolfi

Irene Kazue Miura

627/216. THE CLINICAL UTILITY OF FIBROSCAN IN 1,004 CHILDREN WITH LIVER DISEASES AT SINGLE TERTITARY CENTER

627/181. GENERATION OF A HUMAN INDUCED PLURIPOTENT STEM CELL LINE DERIVED FROM SIBLING PATIENTS WITH ALAGILLE SYNDROME CARRYING JAG1 MUTATION

627/102. CLINICAL PRACTICE GUIDELINES FOR BILIARY ATRESIA IN LATIN AMERICA: RECOMMENDATIONS OF THE LATIN AMERICA SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION (LASPGHAN)

World Health Organization’s goal of elimination of viral hepatitis by 2030. don’t forget the children

Kathleen Schwarz

Severe Acute Hepatitis: an update

Fernando Álvarez

627/216 The clinical utility of fibroscan in 1,004 children with liver diseases at single tertiary center

Chaowapong Jarasvaraparn

627/181 Generation of a human induced pluripotent stem cell line derived from sibling patients with Alagille syndrome carrying JAG1 mutation

Hideki Kumagai

627/102 Clinical practice guidelines for biliary atresia in Latin America: recommendations of LASPGHAN

Elisa De Carvalho

Metabolic dysfunction-associated steatotic liver disease (MASLD): new approaches to understanding the disease in children and its management

Ulrich Baumann

Room C3

Carlos Lifschitz

Suporn Treepongkaruna

627/725. ADAPTATION OF THE DIETARY PROFILE OF CHILDREN UNDER TWO YEARS OF AGE TO THE DIETARY GUIDELINES OF PARAGUAY IN A PEDIATRIC REFERENCE HOSPITAL.

627/331. GLP-1 Medications and Atopic Diseases: A Population Cohort Study

Sarcopenia evaluation in chronic diseases: clinical challenges and future directions

Magali Reyes Apodaca

Iron supplementation in infants: To Do or Not To Do?

Natascha Silva Sandy

627/725 Adaptation of the dietary profile of children under two years of age to the dietary guidelines of paraguay in a pediatric reference hospital

Marta Sanabria

Early nutrition and longterm health

Rosan Meyer

627/331 GLP-1 Medications and Atopic Diseases: A Population Cohort Study

Arleen Delgado

Room D

Anne Griffiths

Colette Deslandres

Diagnostic challenges in low and middle income areas

Almuthe Christina Hauer

How to define the predictive factors of response? How to select the 1st biological?

Jorge Amil Dias

How dietary therapies can be made region-specific and adapted to foods available in diverse geographies

Richard Russell

New target drugs: will they become an affordable option for low-income regions?

Rohan Malik

Room E

Erick Manuel Toro Manjaraz

Annamaria Staiano

Italy

627/155. PYLORIC DISTENSIBILITY PLATEAU: A NOVEL PREDICTOR OF RESPONSE TO INTRAPYLORIC BOTULINUM TOXIN IN CHILDREN AND ADOLESCENTS

Pelvic floor therapy: new therapeutic/preventive

Miguel Angel Carro

Gastroparesis versus functional dyspepsia

Osvaldo Borrelli

627/155 Pyloric distensibility plateau: a novel predictor of response to intrapyloric botulinum toxin in children and adolescents

Peter Osgood

Postural tachycardia syndrome

Gisela Chelimsky

DGBIs from childhood to adulthood: the transition

Miguel Saps

Room A

Suporn Treepongkaruna

Carlos Velasco Benitez

627/264. Early life events and the prevalence of disorders of gut-brain interaction in children aged 0-3 years old–a preliminary study.

627/404. AUTONOMIC MODULATION IS DECREASED IN ADOLESCENTS WITH DISORDERS OF GUT BRAIN INTERACTIONS (DGBI): A STUDY OF 24-HOUR HRV

627/775. ABNORMAL ENTERIC NEURO-REGENERATION UNDERLIES DOWN SYNDROME DYSMOTILITY

Where will the Rome V Criteria go?

Samuel Nurko

What to do with functional nausea?

Marc Benninga

Should biliary disorders be considered in pediatrics within the DGBIs?

Nikhil Thapar

EndoFLIP (Endoluminal functional lumen imaging probe) in pediatrics

José Garza

Room B

Carlos Lifschitz

Marina Orsi

627/79. SELENIUM CONCENTRATIONS IN EXPRESSED HUMAN MILK: A SYSTEMATIC REVIEW AND META-ANALYSIS

Global challenges on breastfeeding promotion

Erika Ochoa Ortiz

Recent WHO complementary feeding guidelines: pros and cons

Mary Fewtrell

If mom cannot breastfeed?

Benjamin D. Gold

Can we move forward to global recommendations with complementary food introduction?

Neelam Mohan

Textures matters: key insights in complementary feeding

Liliana Ladino Melendez

Room C1

Carmen Alicia Sanchez Ramirez

Yunuen Rivera-Suazo

627/235. INCREASING TRENDS OF PEDIATRIC PANCREATITIS: CLINICAL CHARACTERISTICS AND OUTCOMES IN A TERTIARY HOSPITAL IN THAILAND

627/621. Risk Score For The Development of Acute Pancreatitis in Hematopoietic Stem Cell Transplantation (HSCT) And Its Adverse Impact On Mortality.

627/509. Pain relief in chronic pancreatitis – role of pancreatic enzymes, antioxidants, endotherapy and surgery

Acute pancreatitis: An update with severity predictors

Miguel S. Gallardo Luna

Genetic studies in pancreatitis. Where are we?

Michael Wilschanski

Therapeutic strategy in the management of acute and recurrent pancreatitis

Matías Epifanio

Endoscopic approach in chronic pancreatitis

Simona Faraci

Room C2

Karina Leta

Raquel Furnes

627/577. Analysis of the state of the Transition in Gastroenterology Hepatology and Nutrition from Pediatrician to the adult area in LATAM. Working Group Transition LASPGHAN.

627/441. From paediatric to adult care in cystic fibrosis: Measuring patient and parent preparedness

627/182. SURVEY ON TRANSITIONAL CARE TARGETING PHYSICIANS INVOLVED IN PATIENTS WITH HAMARTOMATOUS POLYPOSIS SYNDROME

Transition in adolescence, adherence, healthcare providers. Our experience

Amanda Cantor

Families also make the transition, different perspectives and challenges

Norman Junge

Transitional care for patients with Inflammatory bowel disease: the japanese experience

Hideki Kumagai

The adult perspective

Edgardo Smecuol

Room C3

Ritu Verma

Enriqueta Roman Riechmann

627/167. A GLOBAL SHIFT TOWARDS THE NO-BIOPSY APPROACH IN CHILDREN WITH CELIAC DISEASE

627/667. Is Coeliac Disease diagnosis in children with Diabetes Mellitus without a small bowel biopsy acceptable?

627/558. ULTRA-SHORT CELIAC DISEASE: A PHENOTYPE OF CELIAC DISEASE?

Artificial intelligence and machine learning algorithms in the endoscopic and histopathological diagnosis and follow up of CD patients

María Teresa García de Dávila

Can we move towards a global diagnostic process?

Jernej Dolinsek

What about other autoimmunity pathologies in celiac disease?

Sandhia Naik

Screening for celiac disease in the general pediatric population: has the time come?

Carlo Catassi

Room D

Mirta Ciocca

Fernando Álvarez

627/197. EVALUATION OF THE EFFICACY AND SAFETY OF MARALIXIBAT IN PATIENTS WITH BILIARY ATRESIA AFTER HEPATOPORTOENTEROSTOMY: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (EMBARK)

627/342. BRAZILIAN ALAGILLE SYNDROME STUDY (BASS): RESULTS OF A MULTICENTER OBSERVATIONAL STUDY

627/48. NOVEL MUTATIONS IN FAMILIAL CHOLESTASIS-RELATED GENES BEYOND PFIC1-3 WITH VARIABLE PHENOTYPES AND OUTCOMES: RESULTS FROM A LARGE ARAB STUDY COHORT

Transforming Care in Biliary Atresia: From Pathogenesis to the Bedside

Jorge Abdon Bezerra

Biliary atresia in adolescence and adulthood: challenges on the road to transition

Kathleen Schwarz

Genetic liver disease: Is there a new diagnostic algorithm? Is it applicable worldwide?

Richard Thompson

Novel pharmacological therapies for neonatal cholestasis. Pros and Cons.

Huey-Ling Chen

Room E

Omayma Sabir

Stacy Kahn

627/654. ALTERED GUT MICROBIOME COMPOSITION IN PEDIATRIC TYPE 1 DIABETES MELLITUS: INSIGHTS FROM A CROSS-SECTIONAL STUDY

627/595. INTESTINAL MICROBIOME IN PEDIATRIC PATIENTS:BLENDED VS NON-BLENDED ENTERAL FEEDS

627/578. PILOT STUDY COMPARING THE GUT MICROBIOME OF CHILDREN WITH AND WITHOUT OBESITY

Introduction to Microbiome for the pediatric gastroenterologist

Christian Germán Boggio Marzet

Metagenome sequencing of the gut microbiome in populations all over the world

Ruairi Robertson

Impact of the maternal microbiome on the developing infant across the perinatal period

Flavia Indrio

Opportunities for interventions (trials)

Paul Kelly

Friday 6th december

Room C1

Rodrigo Vázquez Frías

Jordi Espadaler Mazo

Room D

Carlos Lifschitz

Elaine Mosquera

Flavia Indrio

Room E

John Stutts

Jorge Arturo Chávez Saenz

Room A

Sanja Kolaček

Daniel D'Agostino

Roberto Fernández

Room A

Vicky Lee Ng

Laura Delgado

627/459. Summary of the Consensus on the Diagnosis, Treatment, and Follow-Up of Overweight and Obesity in Children and Adolescents by the LASPGHAN

Childhood obesity: Epidemiology, etiology, and pathogenesis 

Jiri Bronsky

Molecular genetic of childhood obesity

Magali Reyes Apodaca

Dietary interventions to prevent childhood obesity

Patricio Acosta Rodríguez Bueno

Advances in treatment of pediatric obesity

Irina Kovalskys

627/459 Summary of the Consensus on the Diagnosis, Treatment, and Follow-Up of Overweight and Obesity in Children and Adolescents by the LASPGHAN

Jaime Ernesto Alfaro Bolaños

Room B

Koen Huysentruyt

Milton Mejía Castro

627/59. The natural evolution of Cow's Milk-related Symptom Score (CoMiSS) in infants not diagnosed with cow´s milk allergy

Strategies to prevent cow´s milk allergy: are we doing our best?

Roberto Berni Canani

Advances in the treatment of IgE-mediated food allergies

Anna Nowak Wegrzyn

627/59 The natural evolution of Cow's Milk-related Symptom Score (CoMiSS) in infants not diagnosed with cow´s milk allergy

Yvan Vandenplas

New allergens in the horizon?

Sylvia Cruchet

Food allergy exclusion diet: growth and QOL-HR challenges

Katia Rodriguez

Room C1

Mauro Batista de Morais

Melvin Heyman

627/261. The Protective Effects of Zonulin Antagonist on the Development of Non-alcoholic Fatty Liver Diseases in a Mice Model

627/774. Bile Acid Analogs Regulate G-Coupled Protein Receptor TGR5 to Mitigate Parenteral Nutrition Associated Complications

627/414. PHASE 2/3 STUDY EVALUATING EFFICACY AND SAFETY OF POZELIMAB IN PATIENTS WITH CD55 DEFICIENCY WITH HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY (CHAPLE DISEASE)

Advances in pediatric acute liver failure (PALF)

Rohit Kohli

627/261 The Protective Effects of Zonulin Antagonist on the Development of Non-alcoholic Fatty Liver Diseases in a Mice

Chun-Yan Yeung

Relationship between gut, liver, microbiome and nutrition

Yen Hsuan Ni

627/774 Bile Acid Analogs Regulate G-Coupled Protein Receptor TGR5 to Mitigate Parenteral Nutrition Associated Complications

Chandra Manithody

Optimal treatment of pediatric IBD: closing the gap through investigator initiated clinical research

Lissy de Ridder

627/414 Phase 2/3 study evaluating efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (Chaple disease)

Voranush Chongsrisawat

Room C2

Natascha Silva Sandy

Kyung Mo Kim

627/560. ROTAVIRUS IN PEDIATRIC LIVER TRANSPLANT PATIENTS: A RETROSPECTIVE ANALYSIS OF INCIDENCE, RISK FACTORS AND OUTCOME

627/255. COMPARING SCORES TO PREDICT MORTALITY IN CHILDREN WITH ACUTE DECOMPENSATION (AD) OF CIRRHOSIS

627/784. Mental health and quality of life in adolescents with solid organ transplantation in times of Pandemic COVID-19

Cardiovascular manifestation following liver transplantation: an update

Norman Junge

627/560 Rotavirus in pediatric liver transplant patients: a retrospective analysis of incidence, risk factors and outcome

Juliana Ramalho de Vasconcelos

Recurrent sclerosing colangitis after liver trasplantation: new concepts

Mercedes Martinez

627/255 Comparing scores to predict mortality in children with acute decompensation (ad) of cirrhosis

Paula Rigo

Optimizing use of technical variant liver allografts

George Mazariegos

627/784 Mental health and quality of life in adolescents with solid organ transplantation in times of Pandemic COVID-19

Tatiana Bendersky

Room C3

Katsuhiro Arai

Sandra Neri

627/697. A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY ON THE APPLICABILITY OF COLD SNARE POLYPECTOMY IN CHILDREN UNDERGOING COLONOSCOPY

627/381. USE OF ENDOSCOPIC FUNCTIONAL LUMINAL IMAGING PROBE DURING PEDIATRIC ESOPHAGEAL DILATION LEADS TO INCREASED MUCOSAL DISRUPTION AND IMPROVEMENT IN SYMPTOMS

627/531. TOPICAL HEMOSTATIC AGENT IN SEVERE GASTROINTESTINAL BLEEDING: EXPERIENCE IN A HIGH-COMPLEXITY ENDOSCOPY UNIT

627/697 A prospective multicenter observational study on the applicability of cold snare polypectomy in children undergoing colonoscopy

Hunter Friesen

Advanced polypectomy with EMR/ESD

Mike Thomson

Endoscopic management of GI fistulae and perforations in children

Paula Peruzzi

627/381 Use of endoscopic functional luminal imaging probe during pediatric esophageal dilation leads to increased mucosal disruption and improvement in symptoms

Raul Sanchez

Endoscopic biliopancreatic interventions in children

Zaheer Nabi

627/531 Topical hemostatic agent in severe gastrointestinal bleeding: experience in a high-complexity endoscopy unit

Laura Busquet

Room D

Sandhia Naik

Enriqueta Roman Riechmann

627/597. DEVELOPMENT OF A REPRODUCIBLE COMPUTATIONAL METHOD TO EVALUATE VILLOUS-CRYPT ARCHITECTURAL METRICS IN HEMATOXYLIN AND EOSIN STAINED DUODENAL BIOPSIES

From pathogenesis to novel therapies

Valentina Discepolo

627/597 Development of a reproducible computational method to evaluate villous-crypt architectural metrics in hematoxylin and eosin stained duodenal biopsies

Jocelyn Silvester

Tolerance, probiotics, and peptidases

Julio César Bai

Is personalized medicine possible in celiac disease (predictors or interventions to prevent disease)?

Luciana Guzmán

Controversies in Celiac Disease and Gluten-related disorders

Stefano Guandalini

Room E

Jorge Arturo Chávez Saenz

Harland Winter

627/533. A FAMILIAL VERY EARLY-ONSET CROHN’S DISEASE BASED REFINEMENT OF DISEASE LOCATION ASSOCIATED GENE NETWORKS

Monogenic disease VEOIBD from the GI clinic

Aleixo Muise

627/533 A familial very early-onset crohn’s disease based refinement of disease location associated gene networks

Ashleigh Watson

Do we have to consider a different diagnostic algorithm in VEOIBD?

Mamoun Elawad

Therapeutic approach in patients with VEOIBD

Victor Navas Lopez

Potential positioning of fecal microbiota transplantation (FMT) and microbial therapeutics into the treatment of IBD

Richard Kellermayer

Room A

Oscar Hincapie

Ruairi Robertson

John Stutts

Room C1

Ailim Margarita Carias Domínguez

2024 Iberoamerican Guidelines on Probiotics for Digestive Health in Children: Evidence based analysis and expertise approach

Sylvia Cruchet

Pedro Gutierrez Castrellon

Guidelines to Reality: Bringing Expert Insights into Clinical Practice Using Saccharomyces boulardii CNCM I-745.

Aldo Maruy Saito

Room C2

George Mazariegos

Adriana Fernández

Veronica Busoni

Room C3

Welcome and Introduction to the Symposium

José Vicente Spolidoro

The Cow’s Milk Related Symptom Score (CoMiSS™)

Yvan Vandenplas

Unleashing the Power of the Microbiome in the Management of CMPA

Anna Nowak Wegrzyn

Room D

Gabriel Vinderola

Real world evidence studies

Norberto Giglio

Effectiveness  of an hydrolized formula with symbiotics

Monica Edith Del Compare

Room E

Lars Bode

Maria Fernanda Elias Llanos

Room A

Samuel Nurko

Melquicedec Vargas Sandoval

627/584. DEVELOPMENT OF THE COLUMBUS PEDIATRIC CONSTIPATION SCORE: A SHORT SURVEY TO PREDICT CONSTIPATION SEVERITY IN CHILDREN

Nutritional approach in DGBI disorders

Annamaria Staiano

Italy

The unavoidable pandemic of DGBI

Carlo Di Lorenzo

Neurostimulation in pediatric DGBI

Neha Santucci

Diagnosis and treatment of oropharyngeal dysphagia

Rachel Rosen

627/584 Development of the Columbus Pediatric Constipation Score: a short survey to predict constipation severity in children

Julia Van der Zande

Room B

Aw Marion

Yalda Lucero

627/587. Single cell transcriptomic for deciphering the pathogenesis of celiac disease

627/662. An in vitro model for celiac disease

627/739. GLUTEN-INDUCED IL-2 RELEASE AS A BIOMARKER OF CELIAC DISEASE IN CHILDREN

Are there new tools to assess adherence to the gluten-free diet?

Carmen Ribes-Koninckx

627/587 Single cell transcriptomic for deciphering the pathogenesis of celiac disease

Giuseppe Molinario

627/662 An in vitro model for celiac disease

Mariam Blanch Ruiz

New diagnostic challenges in GFD-style era

Ritu Verma

627/739 Gluten-induced il-2 release as a biomarker of celiac disease in children

Jocelyn Silvester

Tools to test new therapeutics: from the periphery to the gut

Valentina Discepolo

Room C1

Henkjan J. Verkade

Norberto Rodríguez-Baez

627/582. HUMAN INTESTINAL EPITHELIAL ORGANOID AS A MODEL TO STUDY THE INTERACTION WITH SPECIFIC GLIADIN PEPTIDE

627/148. CALCIUM-FORTIFIED ORAL REHYDRATION SOLUTION IS MORE EFFECTIVE THAN STANDARD ORAL REHYDRATION SOLUTION IN REDUCING DIARRHEA MORBIDITY IN CHOLERA TOXIN-PRETREATED MICE

627/688. Peripheral B cell subsets distribution in children with non-alcoholic fatty liver disease (NAFLD): relationship with selected clinical parameters.

Bridging the disparities in research between low- and high-income countries

Anupam Sibal

627/148 Calcium-fortified oral rehydration solution is more effective than standard oral rehydration solution in reducing diarrhea morbidity in cholera toxin-pretreated mice

Sam Xiajun Cheng

Leveraging multi-center collaborative to advance hepatology research

Jorge Abdon Bezerra

627/688 Peripheral B cell subsets distribution in children with non-alcoholic fatty liver disease: relationship with selected clinical parameters

Piotr Socha

Immunity and microbiota: key regulators of the gut-brain axis

Fernando Chirdo

627/582 Human intestinal epithelial organoid as a model to study the interaction with specific gliadin peptide

Giorgia Fontana

Room C2

Said Ettair

Armando Madrazo de la Garza

627/706. COMPARISON OF MOLECULAR ANTIMICROBIAL RESISTANCE FREQUENCY IN HELICOBACTER PYLORI STRAINS ISOLATED FROM CHILEAN CHILDREN WITH SYMPTOMATIC INFECTION IN 2 PERIODS: 2010-2015 VS 2021-2024.

627/507. A FALLING INCIDENCE OF HELICOBACTER PYLORI INFECTION IN PERUVIAN CHILDREN? FINDINGS FROM A PEDIATRIC GASTROENTEROLOGY UNIT IN LIMA-PERU

627/564. PROBIOTICS INGESTION INCREASES THE REGRESSION RATE OF INTESTINAL METAPLASIA IN NAÏVE HELICOBACTER PYLORI-INFECTED PATIENTS AFTER ERADICATION THERAPY

H. pylori the bad guy: associated diseases in children

Benjamin D. Gold

627/706 Comparison of molecular antimicrobial resistance frequency in Helicobacter pylori strains isolated from Chilean children with symptomatic infection in 2 periods: 2010-2015 vs 2021-2024

Joaquín Ignacio Torres Núñez

627/507 A falling incidence of Helicobacter pylori infection in Peruvian children? Findings from a pediatric gastroenterology unit in Lima-Perú

Ana Muñoz-Urribarri

H. pylori the good guy: benefits of infection in modulating allergic and immune-mediated diseases

Paul Harris

627/564 Probiotics ingestion increases the regression rate of intestinal metaplasia in naïve Helicobacter pylori-infected patients after eradication therapy

Yaolung Yang

H. pylori: are the NASPGHAN/ESPGHAN Guidelines 2023 applicable around the world?

Matjaz Homan

Room C3

Priya Narula

Gabriela Hernández Vez

627/521. PER ORAL ENDOSCOPIC MYOTOMY IS SUCCESSFUL AS PRIMARY TREATMENT FOR ESOPHAGEAL ACHALASIA IN CHILDREN

627/461. Comparison of Single-step vs Two-step Laparoscopic Assisted Percutaneous Endoscopic Gastrojejunostomy Tube Insertion in Children

627/132. Unsedated Transnasal Endoscopy has lower adverse event rate than Sedated Endoscopy in Pediatric and Young Adult Patients

New techniques and devices for non-variceal GI Bleeding

Petar Mamula

627/521 Per oral endoscopic myotomy is successful as primary treatment for esophageal achalasia in children

Muhammad Khan

Endoscopic therapy for obesity (balloons and others)

627/461 Comparison of Single-step vs Two-step Laparoscopic Assisted Percutaneous Endoscopic Gastrojejunostomy Tube Insertion in Children

Ahmed A Nugud

627/132 Unsedated Transnasal Endoscopy has lower adverse event rate than Sedated Endoscopy in Pediatric and Young Adult Patients

Nathalie Nguyen

Potential of balloon-assisted enteroscopy: what can we do with it?

Tomonori Yano

Room D

Jiri Bronsky

Juan Sebastián Pereira Angulo

627/819. Gastric Emptying Rates and Gastrostomy Tube Feeding: A Retrospective Cohort Study of 242 Pediatric Patients

General approach to feeding disorders

Mauro Fisberg

Feeding in neurologically impaired children

Mohamed Miqdady

627/819 Gastric Emptying Rates and Gastrostomy Tube Feeding: A Retrospective Cohort Study of 242 Pediatric Patients

Ryan Shargo

Management of picky eaters

Feeding problems and nutrient intake in children with autism spectrum disorders

Ailim Margarita Carias Domínguez

Room E

Paul Kelly

Aldo Maruy Saito

627/417. Lacticaseibacillus rhamnosus GG (ATCC 53103) restores the antibiotic-induced persistent enteric neuromuscular alterations with a specific gender effect in mice

627/183. Probiotics Enhance Gut Microbiota Balance of Preterm Neonates: A Randomized Controlled Trial

627/94. Study of the microbiota in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) and in Graft-versus-Host Disease (GVHD) and its implications on prognosis

Diet-microbiota interaction: towards a personalized medicine

Rosaura Leis Trabazo

627/417 Lacticaseibacillus rhamnosus GG (ATCC 53103) restores the antibiotic-induced persistent enteric neuromuscular alterations with a specific gender effect in mice

Silvia Salvatore

627/183 Probiotics Enhance Gut Microbiota Balance of Preterm Neonates: A Randomized Controlled Trial

Pornthep Tanpowpong

Tackling the Microbiome through Lifestyle Medicine: The Role of Microbiome Testing

Juan Bustamante

627/94 Study of the microbiota in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) and in Graft-versus-Host Disease (GVHD) and its implications on prognosis

Beatriz Vergara Muñoz

The future of gastrointestinal health: predicting and preventing disease with microbiotic profiling

Stacy Kahn

Room A

Mamoun Elawad

Colette Deslandres

627/51. UNVEILING THE IMPACT ON IN UTERO EXPOSURE TO BIOLOGIC TREATMENTS FOR INFLAMMATORY BOWEL DISEASE (IBD) ON CHILDREN'S PSYCHOMOTOR DEVELOPMENT: INSIGHTS FROM THE DUMBO REGISTRY OF GETECCU.

627/191. Pilot Study of Fecal mtDNA Demonstrates High Sensitivity and Capability to Differentiate Between Histologic Remission and Mild Disease Activity Superior to Fecal Calprotectin

627/679. EFFICACY OF VEDOLIZUMAB IN PEDIATRIC CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Should we tailor small molecule vs. biologic therapeutic options in low- and middle-income areas?

Lee Way Seah

Thinking about nutrient deficiency

Vera Sdepanian

What to do when we lose response to biologic? How to prevent and/or reverse the loss of response to biologics?

Francisco Javier Martín de Carpi

Decisions to make before and after luminal surgery

Anne Griffiths

Room B

Rohit Kohli

Miriam L Cuarterolo

627/280. MICROBIALLY DERIVED VOLATILE METABOLITES IN PEDIATRIC MASLD

627/30. Usefulness of serum microRNAs as biomarkers for pediatric metabolic dysfunction-associated steatotic liver disease (MASLD)

627/744. ASSOCIATION BETWEEN THE GENETIC VARIANT P.I148M OF PNPLA3 AND LIVER STEATOSIS IN ADOLESCENTS FROM THE CHILEAN GROWTH AND OBESITY STUDY COHORT

EASL Clinical Practice Guidelines on genetic cholestatic liver disease

Henkjan J. Verkade

Food insecurity and risk for pediatric fatty liver

Rima Fawaz

Do family, culture, genetics and environment determine fatty liver?

Neelam Mohan

Pediatric Liver Transplantation as Surgical Gene Therapy for Metabolic Disease

George Mazariegos

Room C1

Kerri Gosselin

José Fernando Vera Chamorro

627/137. THE IMPACT OF FUNCTIONAL AND STRUCTURAL GASTROINTESTINAL CONDITIONS ON LONG-COVID DEVELOPMENT AND SUBSEQUENT GASTROINTESTINAL SYMPTOMS: INSIGHTS FROM A GLOBAL HEALTH NETWORK STUDY

627/224. PRO/SYNBIOTICS IMPROVE GUT HEALTH AND REDUCE INFLAMMATION IN INFANTS IN KENYA

627/620. Risk of Gastrointestinal disorders among children with early life exposure to acid suppressive therapy and/or antibiotics.

Environmental Enteric Dysfunction, what are the roles of pathobionts in the pathogenesis?

Paul Kelly

Emerging and old pathogens with digestive implications (TBC, chikungunya, etc)

Anupam Sibal

Antibiotic resistance and its relevance for GI infections including C difficile burden

Andrea Lo Vecchio

Epidemiological transitions of mankind and their effect on infectious diseases

Adrian Diaz

Room C2

José Vicente Spolidoro

Jon Vanderhoof

627/70. INCIDENCE, PREDICTORS AND OUTCOME OF NEONATAL-ONSET INTESTINAL FAILURE

627/303. LONG-TERM USE OF TEDUGLUTIDE IN CHILDREN WITH SHORT BOWEL SYNDROME: A MULTI-CENTER POST-MARKETING COHORT STUDY

627/635. ARE MEDICAL DEVICES RISK FACTORS FOR CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS IN CHILDREN WITH INTESTINAL FAILURE?

Short bowel syndrome and intestinal adaptation

Valeria Cohran

Teduglutide use in children as a treatment for short bowel syndrome

Veronica Busoni

Long term follow up of short bowel syndrome

Olivier Goulet

Intestinal transplantation

Pablo Lobos

Room C3

Reinaldo Pierre-Alvarez

Jenifer Lightdale

627/821. Does Adding Ice lollies and Jelly to Pediatric Colonoscopy Preparation Protocol Improve Patient Compliance and Quality of Preparation?

627/180. Intussusception and endoscopic surveillance in the Peutz–Jeghers Syndrome: a Nationwide Survey in Japan, 2019–2021

627/307. INSUFFLATION PRESSURE REQUIRED TO COLLAPSE OESOPHAGEAL VARICES DURING OESOPHAGOSCOPY

A review of the New Era of Capsule Endoscopy

Ignacio Fernández Urien

Role of Pediatric Endosonography in today´s era

Moinak Sen Sarma

Endoscopic follow-up of patients with EoE: new guidelines and long-term alternatives

Montserrat Cázares Méndez

AI (Artificial Intelligence) in the Pediatric Endoscopy Room

Victor Fox

Room D

Dominique Bailey

Ericka Montijo Barrios

627/385. THE IMPACT OF A MANAGEMENT PATHWAY AND WORKFLOW ON PROCEDURAL STANDARDIZATION AND HISTOLOGIC REMISSION IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS

627/371. EFFECT OF DUPILUMAB ON WEIGHT IN PEDIATRIC PATIENTS AGED 1 TO LESS THAN 12 YEARS WITH ACTIVE EOE ENROLLED IN THE PHASE 3 KIDS STUDY

Update on the epidemiology of Eosinophilic Esophagitis: What factors of change should we consider?

Michelle Higuera

Current diagnostic approach of Eosinophilic Esophagitis

Mario Vieira

Gastrointestinal eosinophilic disease: beyond esophagitis

Mohamed Miqdady

Are ESPGHAN/NASPGHAN Guidelines on Eosinophilic Gastrointestinal Disorders Beyond the Esophagus applicable around the world?

Alexandra Papadopoulou

Therapeutic developments in eosinophilic esophagitis and their effectiveness

Jorge Amil Dias

Room E

Gilda Porta

Norman Junge

627/628. Could delta FIB-4, delta APRI and delta ALBI scores predict transplant-free survival in patients with biliary atresia submitted to Kasai procedure?

627/34. MobileNetV2_HCC_class: A Novel Tool for Predicting Hepatocellular Carcinoma Recurrence After Resection or Liver Transplantation

627/47. Newborn Liver Transplantation for Neonatal Liver Failure: A Challenging Scenario Needing Extraordinary Measures

Endoscopic Management of Chronic Pancreatitis in Children Including Placement of Metallic Stent

Kyung Mo Kim

Should living donor be almost always the first graft option in pediatric liver transplants?

Joao Seda

Care of the long-term survivor of pediatric liver transplantation in 2024; definitely not just about the liver

Vicky Lee Ng

LDLT in the setting of acute on chronic liver failure

Rubén Quiros-Tejeira

Room D

Health care professionals and AI: Adapt or Be Left Behind

Hania Szajewska

Innovative Approaches in Pediatric Gastroenterology: Machine Learning for Stool Consistency Assessment

Yvan Vandenplas

The future is here: enhancing pediatric care with Artificial Intelligence

Gabriel Vinderola

Saturday 7th december

Room A

Suporn Treepongkaruna

Marina Orsi

Fernando Chirdo

Room A

Jorge Palacios Rosales

Hania Szajewska

627/7. THE INTRICATED INTERPLAY BETWEEN ATOPY AND DYSBIOSIS IN A PEDIATRIC POPULATION WITH FUNCTIONAL ABDOMINAL PAIN

627/104. HEALTH OUTCOMES OF INFANT FORMULA SUPPLEMENTED WITH HUMAN MILK OLIGOSACCHARIDE ANALOGUES: A SYSTEMATIC REVIEW BY THE ESPGHAN SPECIAL INTEREST GROUP ON GUT MICROBIOTA AND MODIFICATIONS

627/397. Does small intestinal bacterial overgrowth predict outcome in cirrhosis?

Latest advances in the infant microbiome: the mycobiome in early-life immune and metabolic development

Marie Claire Arrieta

627/7 The intricated interplay between atopy and dysbiosis in a pediatric population with functional abdominal pain

Oana Belei

Give the bugs or feed the bugs?

Juan José Díaz Martín

627/104 Health outcomes of infant formula supplemented with human milk oligosaccharide analogues: a systematic review by the espghan special interest group on gut microbiota and modifications

Yvan Vandenplas

SIBO

José Garza

627/397 Does small intestinal bacterial overgrowth predict outcome in cirrhosis?

Moinak Sen Sarma

Room B

Sylvia Cruchet

Alez Noberto Elizarrarás

Nutritional requirements for a healthy diet

Irina Kovalskys

Sugar in infants, children and adolescents

Jiri Bronsky

Feasibility of plant based diets for children

Erika Ochoa Ortiz

No Gluten, No Milk or FODMAPS diets

Katia Rodriguez

Room C1

Thomas Attard

Isabel Rojas

Pediatric polyposis syndromes: an easy guide

Shlomi Cohen

Extracolonic surveillance in pediatric polyposis: guidelines and beyond

Thomas Attard

Familial adenomatous polyposis: keeping the colon

Nakayama Yoshiko

Psychosocial challenges and transition of care in children with polyposis

Michele Maddux

Polypectomy: avanced techniques

Mike Thomson

Room C2

Mario Vieira

Room C3

Mercedes Martinez

Alejandro Costaguta

627/365. HEPATOBILIARY SCTINTIGRAPHY AS A PROGNOSTIC MARKER FOR PAEDIATRIC ACUTE LIVER FAILURE

Recurrent acute liver failure: diagnosis and management

Gilda Porta

627/365 Hepatobiliary sctintigraphy as a prognostic marker for paediatric acute liver failure

Louise Cai

Gene therapy: an update

Lorenzo D'Antiga

Congenital porto-systemic shunts: imaging tests and guidelines

Riccardo Superina

Novel concepts in porto-sinusoidal disorder in children

José Ernesto Lipsich

Room D

Monica Contreras

Lissy de Ridder

627/753. AUTOMATIC PEDIATRIC INFLAMMATORY BOWEL DISEASE ASSESSMENT IN INTESTINAL ULTRASOUND IMAGES USING MACHINE LEARNING

IUS-IBD, What can you tell us? Will it be part of every medical visit?

Michael Winter

627/753 Automatic pediatric inflammatory bowel disease assessment in intestinal ultrasound images using machine learning

Hien Huynh

When a child is ready to become an adult: transition of care in IBD

Eytan Wine

Transition experience in LatinAmerica

Juan Andrés De Paula

Fertility and breastfeeding still in the biologic era

Rachel Winter

Room E

Lucia Escobedo Berumen

Roman Bigliardi

627/572. PHARMACOLOGICAL TREATMENT OPTIONS FOR FUNCTIONAL CONSTIPATION IN CHILDREN

627/572 Pharmacological treatment options for functional constipation in children

Anna de Geus

Refractory constipation: medical and surgical treatment

Leonel Rodríguez

Psychotherapy, hypnotherapy, food and drugs in DGBIs

Andrés Bodas Pinedo

Central neuromodulators in the treatment of DGBIs

Desalegn Yacob

Autism spectrum disorder and gastrointestinal (GI) symptoms

Joseph Croffie

Room A